|
|
 |
|
Viewing report
|
|
|
|
An Introduction to Pharmacovigilance
John Wiley and Sons Ltd, Oct 2009, Pages: 120
Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problems.
This introductory guide is designed to aid the rapid understanding of the key principles of pharmacovigilance. Packed full of examples illustrating drug safety issues it not only covers the processes involved, but the regulatory aspects and ethical and societal considerations of pharmacovigilance.
Covering the basics step-by-step, this book is perfect for beginners and is essential reading for those new to drug safety departments and pharmaceutical medicine students.
Most practitioners in pharmacovigilance work in the pharmaceutical industry or in regulatory authorities - this book specifically considers the subject from the perspective of that interface. There are few textbooks in the field and those that are published are large and too detailed to be of value to the new entrant. Currently, there is no short introductory textbook, newcomers therefore can only learn on the job or through training courses. This book will be an alternative or supplement to basic training courses in the field.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Personalized Medicine - Scientific and Commercial Aspects
Stephens' Detection and Evaluation of Adverse Drug Reactions: Principles and Practice (6th Edition)
Benchmarking Drug Safety and Pharmacovigilance
Central and Core Laboratories 2011
Applications of Microdialysis in Pharmaceutical Science
Drug Safety in China: A Strategic Stake for Healthcare Companies
Pain Therapeutics - Drugs, Markets and Companies
Drug Discrimination: Applications to Medicinal Chemistry and Drug Studies
Pharmaceutical Data Mining: Approaches and Applications for Drug Discovery
3rd Annual Pharmacovigilance 2012 - Ensuring safer drugs to market by analyzing latest developments in pharmacovigilance, drug safety and risk management
|
|
|
|
